Platinum Sponsor
Join the Alliance for Regenerative Medicine (ARM) in Washington, DC for our upcoming Workshop, where industry leaders, regulators, clinicians and patient advocates will gather to explore the next phase of the cell and gene therapy (CGT) sector.
This two-day program will dive into the scientific, regulatory, and patient access challenges shaping the field, with a focus on scaling advanced therapies to reach more patients worldwide.
Program highlights include case studies on scale-in, scale-out, and scale-up strategies from leading developers as the field advances both autologous and allogeneic CGTs toward industrialization, innovations in viral and non-viral delivery on day 1. On day 2, the program will focus on patient access in the community and advances in analytics that accelerate drug release, as well as a regulatory panel discussion. The program will include ample time for networking and continuing conversations at a Networking Reception in the evening of November 5th.
Registration for ARM members is complimentary. The rates for non-members is below.
Industry Non-ARM Members: $1,000 (In-Person Pass) | $150 (Virtual Pass)
Academic/Non-Profit Non-ARM Members: $375 (In-Person Pass) | $75 (Virtual Pass)
Platinum
20 F St. NW Conference Center
20 F St NW
Washington, DC
This event does not have a dedicated room block at any hotel property. Please see below for suggested accommodations:
The Royal Sonesta Capitol Hill (Across the street from venue)
Hilton Washington DC Capitol Hill (0.2 miles from venue)
Our team is ready to help. Contact Natalie Fekete at [email protected].
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.
